Skip to main content
. 2016 May 9;34(24):2820–2826. doi: 10.1200/JCO.2016.66.6313

Fig 1.

Fig 1.

Percentage increase in total and adjusted costs of care from breast cancer diagnosis until death for extreme users of disease-monitoring testing. Adjusted for costs of disease-monitoring testing, including serum tumor-marker tests and radiographic imaging and analyzed by using natural log transformation by multivariable linear regression adjusted for characteristics displayed in Table 1 (20 participants not included due to no cost data). P < .001 for all values.